全球急救吸入器市場

預計到 2030 年全球急救吸入器市場規模將達 281 億美元

全球急救吸入器市場規模預計在2024年為178億美元，預計到2030年將達到281億美元，2024年至2030年期間的複合年成長率為7.9% 。定量噴霧吸入器是本報告分析的細分市場之一，預計其複合年成長率為9.2%，到分析期結束時規模將達到122億美元。乾粉吸入器細分市場在分析期間的複合年成長率預計為7.1%。

美國市場規模估計為 48 億美元，中國市場預計複合年成長率為 12.5%

美國急救吸入器市場規模預計在2024年達到48億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到61億美元，在2024-2030年的分析期間內，複合年成長率為12.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.9%和7.6%。在歐洲，預計德國市場的複合年成長率為5.3%。

全球「救援吸入器」市場—主要趨勢與促進因素摘要

救援吸入器是否仍是全球急性呼吸道疾病救治的生命線？

急救吸入器，主要是短效BETA受體促效劑(SABA)，在緩解急性氣喘發作和喘息、咳嗽和呼吸急促等突發性呼吸道症狀方面繼續發揮著至關重要的作用。這些吸入藥物是速效支氣管擴張劑，透過在幾分鐘內放鬆氣道肌肉和打開呼吸道來發揮作用。儘管長期氣喘控制療法取得了進展，但急救吸入器仍然是緊急呼吸情況下的第一道防線，特別是對於兒童、老年人和監測不力的患者。隨著全球氣喘和慢性阻塞性肺病(COPD) 盛行率的上升，對有效、速效吸入療法的需求持續成長，特別是在都市區和工業地區。急救吸入器不僅可以挽救生命，也是氣喘行動計畫和 COPD 管理通訊協定的基石，使其成為呼吸照護的主要支柱。

吸入器技術如何改善可近性、輸送性和患者依從性？

技術進步正在將急救吸入器轉變為更有效率、易於使用和數位整合的醫療設備。定量噴霧吸入器(MDI) 已發展出改進的劑量計數器、人體工學設計和推進劑創新，以提高藥物傳輸的準確性。乾粉吸入器 (DPI) 為協調性差的患者提供了呼吸活化的替代方案。結合藍牙感測器和配套行動應用程式的智慧吸入器現在可以追蹤吸入模式、給藥頻率並發出警報以確保依從性和早期療育。此類創新對於管理兒科和慢性病患者的看護者和醫療保健提供者尤其有價值。製藥公司也專注於新興市場和緊急應變環境的耐熱配方和緊湊型設備設計。這些發展改善了治療效果，使患者能夠更好地控制呼吸系統疾病。

哪些患者人口統計和醫療保健環境推動了救援吸入器的採用？

急救吸入器廣泛應用於多種人群，但對於氣喘、慢性阻塞性肺病和運動誘發的支氣管痙攣患者至關重要。在兒童中，它們通常用作過敏症發作的第一線藥物，尤其是在學校和家庭環境中。患有合併呼吸系統疾病的老年患者使用急救吸入器來控制急性慢性阻塞性肺病發作並盡量減少住院治療。急診室、救護車和緊急護理機構將急救吸入器作為即時干預的必需庫存。工廠、建築工地和多塵行業的職業健康服務也隨時準備好應對職場引起的呼吸緊急情況。由於空氣污染、都市區過敏原和氣候相關的呼吸系統惡化因素的增加，所有年齡和地區對急救吸入器的需求都在擴大。這種多樣化的用途凸顯了它們在急性呼吸照護中不可替代的作用。

是什麼推動了全球救援吸入器市場的成長？

救援吸入器市場的成長得益於呼吸系統疾病盛行率的上升、吸入器設計的技術創新以及人們對氣喘和慢性阻塞性肺病自我管理意識的不斷提高。從技術上講，智慧吸入器、呼吸驅動機制和下一代氣霧劑配方正在提高易用性和治療效果。從最終用途的角度來看，氣喘和慢性阻塞性肺病盛行率的上升（尤其是在中低收入國家）持續推動需求。擴大採用以學校為基礎的氣喘計畫、職場應急套件和遠端醫療呼吸監測來支持更廣泛的獲取和依從性。學名藥藥和成藥藥的監管核准使這些產品更加經濟實惠和易於獲得。此外，污染激增和季節性過敏原等環境變化正在增加吸入器的使用頻率和緊迫性。這些因素共同推動了全球對救援吸入器在臨床和社區環境中的需求強勁成長。

部分

產品類型（定量噴霧吸入器、乾粉吸入器、霧化器、緩霧吸入器、其他產品類型）、適應症（氣喘、慢性阻塞性肺病、過敏性鼻炎、肺動脈高血壓、其他適應症）、患者類型（成人、兒童）、劑型（膠囊、溶液、混懸液、其他劑型）、最終用戶（家庭護理環境、醫院和診所）

受訪企業範例（共48家）

• 3M
• Apotex Inc.
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cipla
• Dr. Reddy's Laboratories
• GlaxoSmithKline（GSK）
• Hikma Pharmaceuticals
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Mundipharma
• Mylan
• Novartis
• Orion Corporation
• Sandoz（a Novartis division）
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Vectura Group
• Viatris Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Rescue Inhalers Market to Reach US$28.1 Billion by 2030

The global market for Rescue Inhalers estimated at US$17.8 Billion in the year 2024, is expected to reach US$28.1 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Metered Dose Inhalers, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth in the Dry Powder Inhalers segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.8 Billion While China is Forecast to Grow at 12.5% CAGR

The Rescue Inhalers market in the U.S. is estimated at US$4.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global "Rescue Inhalers" Market - Key Trends & Drivers Summarized

Are Rescue Inhalers Still The Lifeline For Acute Respiratory Relief Worldwide?

Rescue inhalers, primarily short-acting beta-agonists (SABAs), remain critical in providing immediate relief from acute asthma attacks and other sudden respiratory symptoms such as wheezing, coughing, and shortness of breath. These inhalers are fast-acting bronchodilators that work by relaxing airway muscles and opening up breathing passages within minutes. Despite advances in long-term asthma control therapies, rescue inhalers continue to be the frontline defense in emergency respiratory situations, especially in pediatric, elderly, and under-monitored patients. As the global prevalence of asthma and chronic obstructive pulmonary disease (COPD) rises, particularly in urban and industrialized regions, the demand for effective, rapid-response inhalation therapies remains robust. Rescue inhalers are not only life-saving but also foundational to asthma action plans and COPD management protocols, making them a mainstay in respiratory care.

How Are Inhaler Technologies Improving Accessibility, Delivery, And Patient Compliance?

Technological advancements are transforming rescue inhalers into more efficient, user-friendly, and digitally integrated medical devices. Metered-dose inhalers (MDIs) have evolved with improved dose counters, ergonomic designs, and propellant innovations to enhance drug delivery precision. Dry powder inhalers (DPIs) offer breath-actuated alternatives for patients who struggle with coordination. Smart inhalers embedded with Bluetooth sensors and companion mobile apps now track inhalation patterns, dosage frequency, and trigger alerts to ensure adherence and early intervention. These innovations are particularly valuable for caregivers and healthcare providers in managing pediatric and chronic patients. Pharmaceutical companies are also focusing on heat-stable formulations and compact device designs for emerging markets and emergency response settings. These developments are collectively improving treatment efficacy and empowering patients with better control over their respiratory conditions.

Which Patient Demographics And Healthcare Settings Drive Rescue Inhaler Utilization?

Rescue inhalers are widely used across multiple demographics, but they are most critical for patients with asthma, COPD, and exercise-induced bronchospasm. Pediatric populations often rely on them as first-line relief for allergy-induced attacks, especially in school and home environments. Elderly patients with comorbid respiratory conditions use rescue inhalers to manage acute COPD episodes and minimize hospitalizations. Emergency departments, ambulances, and urgent care facilities maintain rescue inhalers as essential stock for immediate intervention. Occupational health services in factories, construction sites, and high-dust industries also keep them on hand for workplace-triggered respiratory emergencies. The rise in air pollution, urban allergens, and climate-induced respiratory aggravators is expanding the need for rescue inhalers across all age groups and geographies. These diverse use environments underscore their irreplaceable role in acute respiratory care.

What’s Fueling Growth In The Global Rescue Inhalers Market?

The growth in the rescue inhalers market is driven by rising respiratory disease incidence, technological innovation in inhaler design, and increased awareness around asthma and COPD self-management. Technologically, smart inhalers, breath-actuated mechanisms, and next-gen aerosol formulations are enhancing usability and therapeutic effectiveness. From an end-use perspective, expanding asthma and COPD prevalence-especially in low- and middle-income countries-continues to push volume demand. Increased adoption of school-based asthma programs, workplace emergency kits, and telehealth respiratory monitoring are supporting broader access and adherence. Regulatory approvals of generic rescue inhalers and OTC options are making these products more affordable and accessible. Additionally, environmental changes such as pollution spikes and seasonal allergens are increasing both the frequency and urgency of inhaler use. Together, these factors are sustaining strong and growing global demand for rescue inhalers in both clinical and community-based settings.

SCOPE OF STUDY:

The report analyzes the Rescue Inhalers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers, Other Product Types); Indication (Asthma, COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, Other Indications); Patient Type (Adult, Pediatric); Form (Capsules, Solution, Suspension, Other Forms); End-User (Home Care Settings, Hospitals & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• 3M
• Apotex Inc.
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici
• Cipla
• Dr. Reddy's Laboratories
• GlaxoSmithKline (GSK)
• Hikma Pharmaceuticals
• Lupin Pharmaceuticals
• Merck & Co., Inc.
• Mundipharma
• Mylan
• Novartis
• Orion Corporation
• Sandoz (a Novartis division)
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Vectura Group
• Viatris Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Rescue Inhalers - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Asthma and COPD Propels Global Demand for Fast-Acting Rescue Inhalers
  • Increased Awareness Campaigns and Early Diagnosis Efforts Drive Inhaler Prescriptions
  • Innovation in Breath-Activated and Dose-Tracking Inhaler Devices Improves Patient Adherence
  • Wider Insurance Coverage and Public Healthcare Access Expand Treatment Availability
  • Introduction of Generic Alternatives Lowers Cost and Expands Access in Emerging Markets
  • Rise in Air Pollution and Allergen Exposure Sustains Chronic Respiratory Illness Burden
  • Digital Integration With Mobile Apps Enhances Usage Tracking and Clinical Monitoring
  • Growing Pediatric and Geriatric Use Cases Drive Market Segmentation Opportunities
  • Partnerships Between Pharma and Telehealth Platforms Expand Digital Distribution
  • Regulatory Support for OTC Asthma Medications Fuels Retail-Based Inhaler Access
  • Clinical Advancements in Combination Therapies Strengthen Competitive Product Portfolios
  • Shortage of Rescue Medications in Remote Regions Presents Public Health Challenges
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Rescue Inhalers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Rescue Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Dry Powder Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Dry Powder Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Dry Powder Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Soft Mist Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Soft Mist Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Soft Mist Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Allergic Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pulmonary Arterial Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pulmonary Arterial Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Pulmonary Arterial Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Solution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Solution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Suspension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Suspension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Suspension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 59: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: USA 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 62: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: USA Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: USA 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 65: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: USA Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: USA 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 68: USA Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: USA 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 74: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Canada Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Canada 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Canada Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Canada 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Canada 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Canada 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• JAPAN
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 89: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Japan Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Japan 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Japan 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Japan 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Japan 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• CHINA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: China 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: China 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: China 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: China 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• EUROPE
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Rescue Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Europe 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Europe 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Europe 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Europe 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• FRANCE
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 137: France Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: France 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: France 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 143: France Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: France Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: France 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 146: France Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: France 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• GERMANY
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Germany 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 155: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Germany Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Germany 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 158: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Germany Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Germany 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Germany 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 167: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Italy Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Italy 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 170: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Italy Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Italy 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 173: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Italy Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Italy 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Italy 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 182: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: UK Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: UK 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 185: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: UK Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: UK 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 188: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: UK Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: UK 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 191: UK Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: UK 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 197: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Spain Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Spain 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 200: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Spain Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Spain 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 203: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Spain Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Spain 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Spain 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 212: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Russia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Russia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 215: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Russia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Russia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 218: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Russia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Russia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Russia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Europe Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Europe 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Europe Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Europe 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Europe Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Europe 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Asia-Pacific Historic Review for Rescue Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Asia-Pacific Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Asia-Pacific Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 260: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Australia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Australia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 263: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Australia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Australia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 266: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Australia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Australia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 269: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Australia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• INDIA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 275: India Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: India Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: India 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: India Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: India Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: India 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 281: India Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: India Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: India 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 284: India Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: India 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 290: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: South Korea Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: South Korea 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 293: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: South Korea Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: South Korea 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 296: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: South Korea Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: South Korea 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: South Korea 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 320: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 321: Latin America Historic Review for Rescue Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Latin America 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 323: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Latin America Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Latin America 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 326: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Latin America Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Latin America 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Latin America 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 338: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Argentina Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Argentina 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 341: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Argentina Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Argentina 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 344: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Argentina Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Argentina 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Argentina 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 353: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Brazil Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Brazil 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 356: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Brazil Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Brazil 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 359: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Brazil Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Brazil 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Brazil 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 368: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Mexico Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Mexico 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 371: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Mexico Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Mexico 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 374: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Mexico Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Mexico 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Mexico 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Latin America Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Latin America Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Latin America Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 398: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 399: Middle East Historic Review for Rescue Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Middle East 15-Year Perspective for Rescue Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 401: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Middle East Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Middle East 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 404: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Middle East Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Middle East 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Middle East 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 416: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Iran Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Iran 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 419: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Iran Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Iran 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 422: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Iran Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Iran 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 425: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Iran 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 431: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Israel Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Israel 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 434: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Israel Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Israel 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 437: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Israel Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Israel 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 440: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Israel 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Saudi Arabia Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Saudi Arabia Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Saudi Arabia Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 461: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: UAE Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: UAE 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 464: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: UAE Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: UAE 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 467: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: UAE Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: UAE 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 470: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: UAE 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: Rest of Middle East Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: Rest of Middle East Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: Rest of Middle East Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030
• AFRICA
  • Rescue Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 491: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Africa Historic Review for Rescue Inhalers by Product Type - Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: Africa 15-Year Perspective for Rescue Inhalers by Product Type - Percentage Breakdown of Value Sales for Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers, Soft Mist Inhalers and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 494: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Africa Historic Review for Rescue Inhalers by Indication - Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: Africa 15-Year Perspective for Rescue Inhalers by Indication - Percentage Breakdown of Value Sales for Other Indications, Asthma, COPD, Allergic Rhinitis and Pulmonary Arterial Hypertension for the Years 2015, 2025 & 2030
  • TABLE 497: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Patient Type - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Africa Historic Review for Rescue Inhalers by Patient Type - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: Africa 15-Year Perspective for Rescue Inhalers by Patient Type - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2015, 2025 & 2030
  • TABLE 500: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for Rescue Inhalers by Form - Capsules, Solution, Suspension and Other Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Africa 15-Year Perspective for Rescue Inhalers by Form - Percentage Breakdown of Value Sales for Capsules, Solution, Suspension and Other Forms for the Years 2015, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Rescue Inhalers by End-user - Home Care Settings and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Rescue Inhalers by End-user - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals & Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION